You are here
32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) / 21st Annual Conference on Rehabilitation in MS
The 2016 ECTRIMS Congress will be the first ever held in the United Kingdom, a country that has contributed much to research and treatment in MS. Many excellent UK-based scientists and clinicians have focused their career on MS, none more so than Professor Ian McDonald, who was active during the latter decades of the twentieth century and whose name is given to the McDonald diagnostic criteria. It is indeed appropriate that the United Kingdom will host an ECTRIMS Congress.
The Congress will offer comprehensive and exciting scientific and teaching programmes. A preliminary scientific programme has been developed with the assistance of the Local Organising Committee. There will be plenary, platform, young investigator, hot topic (some in a debate format) and poster sessions. Themes will include disease mechanisms, prognostic markers, developments in imaging, approaches to early treatment, the latest clinical trial results, and emerging targets for modulation of the innate immune system, neuroprotection and repair. While MS is the main focus, there will be talks on other inflammatory demyelinating CNS diseases. There will be a special section of the programme for MS nurses and symposia sponsored by the European Charcot Foundation and industry. The meeting will also partner with the Annual Conference of Rehabilitation in MS (RIMS).
Main topics include:
- Early treatment approaches
- Long term treatment effects
- B-cell depletion therapies
- Modulation of the innate immune system
- Neuroprotection and repair
- Prognostic markers
- Imaging update
- Genetic and environmental factors
- Jointly with RIMS (Rehabilitation in MS)